CALL US:022-6101 1700   sales@saffronmedia.in
HOME NEWS INGREDIENT MART EVENTS TOPICS INTERVIEW EDIT
 
News
 
Laxmi Yadav, Mumbai May 15 , 2021
The MP Industrial Development Corporation Limited (MPIDC) has decided to allow supply of oxygen to pharmaceutical units manufacturing lifesaving drugs following intervention of Indore MP Shankar Lalwani.

Lalwani had taken up issue related to stoppage of oxygen supply to the drug industry with Indore district collector Manish Singh following a representation by Madhya Pradesh Small Scale Drug Manufacturers’ Association (MPSDMA).

In a representation, MPSDMA stated that the state government’s decision to curtail supply of oxygen to drug units making injectables like ampoules has resulted in stoppage of production of several low-cost Covid-19 drugs -- dexamethasone, ranitidine, maxeron which are often available in glass ampoules. Oxygen cylinder is used in ampoule filling. An injectable unit requires 10-14 oxygen cylinders a week. Exporters were facing challenges to meet export commitments in the wake of stoppage of production at drug units in absence of supply of oxygen.

The Madhya Pradesh government had on April 7, 2021 diverted oxygen supply for health facilities after reports of oxygen shortage in the state leading to the death of Covid-19 patients.

Following this, MPSDMA had on April 9, 2021 written to Indore district collector urging him to allow the supply of oxygen cylinder to pharmaceutical manufacturers who are engaged in manufacturing of ampoules and injections.

As per the decision of the district disaster management committee, Indore district administration banned supply of oxygen for industrial use to meet growing demand for Covid patients.

Following Lalwani’s intervention, MPIDC on May 11, 2021 came out with an amended order instructing oxygen and nitrogen suppliers to maintain supply to 10 pharmaceutical units located in Indore and Pithampur. However, the ban on supply to other industries will remain.

The units which were allocated oxygen and nitrogen cylinders included Modern Laboratories, Nandan Medical Laboratories, Sellwell Pharmaceuticals, Schon Pharmaceuticals, DJ Laboratories, Syncom Formulations, Vindas Chemical Industries, Macleod Pharma, Glenmark Pharma, Chemfusion Chemicals Pvt Ltd.

Said Amit Chawla, general secretary, MPSDMA, “We thanked MP Lalwani and MPIDC for allowing the supply of oxygen and nitrogen to some of the pharmaceutical units. Oxygen is used in the preparation of certain injections that are being used as a supporting drug in treatment of Covid-19 patients. These injections are being supplied daily to government hospitals. Exporters who were facing difficulty in meeting export obligations due to stoppage of oxygen supply can now heave a sigh of relief.”

Share This Story

Leave a Reply
Your name (required)   Your email (required)
         
Website (required)
   
CommenT
 
Enter Code (Required)

 

 

 
INGREDIENT MART

RECENT NEWS

TOPICS
That foods might provide therapeutic benefits is clearly not a new concept. ...

 

MAIN LINKS OUR SERVICES OTHER PRODUCTS ONLINE MEDIA  
 
About Us
Contact Us
News Archives
 

Product Finder
Features and Articles
News
 
Chronicle Pharmabiz
Food & Bevergae News
Ingredients South Asia
 
Media Information
Rate Card
Advertise
 
 
Copyright © 2023 Saffron Media Pvt Ltd. All Rights Reserved.
Best View in Chrome (103.0) or Firefox (90.0)